Xponance, Inc. Eli Lilly & CO Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Xponance, Inc. holds 186,689 shares of LLY stock, worth $147 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares

186,689

Previous 194,824 4.18%

Holding current value

$147 Million

Previous $176 Million 6.23%

% of portfolio

1.62%

Previous 1.82%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $6.28 Million - $7.81 Million	-8,135 Reduced 4.18%	186,689 $165 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $189,915 - $238,168	-262 Reduced 0.13%	194,824 $176 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $2.41 Million - $3.23 Million	4,077 Added 2.13%	195,086 $152 Million
Q4 2023 Jan 31, 2024	BUY	$525.19 - $619.13 $902,276 - $1.06 Million	1,718 Added 0.91%	191,009 $111 Million
Q3 2023 Oct 23, 2023	BUY	$434.7 - $599.3 $256,473 - $353,587	590 Added 0.31%	189,291 $102 Million
Q2 2023 Jul 13, 2023	BUY	$350.74 - $468.98 $7.62 Million - $10.2 Million	21,738 Added 13.02%	188,701 $88.5 Million
Q1 2023 Apr 17, 2023	BUY	$310.63 - $364.82 $1.3 Million - $1.53 Million	4,192 Added 2.58%	166,963 $57.3 Million
Q4 2022 Jan 23, 2023	BUY	$321.55 - $374.67 $5.29 Million - $6.17 Million	16,459 Added 11.25%	162,771 $0
Q3 2022 Oct 24, 2022	BUY	$296.48 - $337.87 $3.09 Million - $3.53 Million	10,436 Added 7.68%	146,312 $47.3 Million
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $208,490 - $244,797	748 Added 0.55%	135,876 $44.1 Million
Q1 2022 Apr 20, 2022	BUY	$234.69 - $291.66 $3.64 Million - $4.52 Million	15,489 Added 12.95%	135,128 $38.7 Million
Q4 2021 Jan 31, 2022	SELL	$224.85 - $279.04 $688,715 - $854,699	-3,063 Reduced 2.5%	119,639 $33 Million
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $2.48 Million - $3.06 Million	-11,206 Reduced 8.37%	122,702 $28.4 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $2.8 Million - $3.62 Million	-15,512 Reduced 10.38%	133,908 $30.7 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $74,765 - $96,787	-455 Reduced 0.3%	149,420 $27.9 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $111,021 - $146,908	851 Added 0.57%	149,875 $25.3 Million
Q3 2020 Oct 26, 2020	SELL	$146.22 - $169.13 $1.16 Million - $1.35 Million	-7,957 Reduced 5.07%	149,024 $22.1 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $21.4 Million - $25.8 Million	156,981 New	156,981 $25.8 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account